BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 33147451)

  • 1. HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon.
    Miner JJ; Platt DJ; Ghaznavi CM; Chandra P; Santeford A; Menos AM; Dong Z; Wang ER; Qian W; Karozichian ES; Philips JA; Apte RS
    Cell Rep; 2020 Nov; 33(5):108339. PubMed ID: 33147451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
    Stanifer ML; Kee C; Cortese M; Zumaran CM; Triana S; Mukenhirn M; Kraeusslich HG; Alexandrov T; Bartenschlager R; Boulant S
    Cell Rep; 2020 Jul; 32(1):107863. PubMed ID: 32610043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
    Park A; Iwasaki A
    Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
    Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
    Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
    Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.
    O'Brien TR; Thomas DL; Jackson SS; Prokunina-Olsson L; Donnelly RP; Hartmann R
    Clin Infect Dis; 2020 Sep; 71(6):1410-1412. PubMed ID: 32301957
    [No Abstract]   [Full Text] [Related]  

  • 11. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-stimulated gene 15 (ISG15) restricts Zika virus replication in primary human corneal epithelial cells.
    Singh PK; Singh S; Farr D; Kumar A
    Ocul Surf; 2019 Jul; 17(3):551-559. PubMed ID: 30905842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin.
    Royer DJ; Carr DJ
    Mucosal Immunol; 2016 Jul; 9(4):1065-75. PubMed ID: 26627457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
    Parker ZM; Pasieka TJ; Parker GA; Leib DA
    J Virol; 2016 Dec; 90(23):10789-10799. PubMed ID: 27681121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus and Host Interactions: From the Bench to the Bedside and Beyond.
    Limonta D; Hobman TC
    Cells; 2020 Nov; 9(11):. PubMed ID: 33198165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology.
    Philip DT; Goins NM; Catanzaro NJ; Misumi I; Whitmire JK; Atkins HM; Lazear HM
    mBio; 2024 Apr; 15(4):e0262323. PubMed ID: 38426749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and evasion of type I interferon responses by SARS-CoV-2.
    Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
    Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III interferons disrupt the lung epithelial barrier upon viral recognition.
    Broggi A; Ghosh S; Sposito B; Spreafico R; Balzarini F; Lo Cascio A; Clementi N; De Santis M; Mancini N; Granucci F; Zanoni I
    Science; 2020 Aug; 369(6504):706-712. PubMed ID: 32527925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.